Effect of berberine on left ventricular remodeling in renovascular hypertensive rats

Yaoxue Xuebao

Volumn 42, Issue 3, 2007, Pages 336-341

  Zhao, Hai Ping ^a   Hong, Ying ^a   Xie, Jun Da ^a   Xie, Xin Ran ^a   Wang, Jing ^a   Fan, Jiang Bo ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

2K2C model; Berberine; Left ventricular remodeling

Indexed keywords

BERBERINE; COLLAGEN; CYCLIC AMP; CYCLIC GMP; NITRIC OXIDE;

ANIMAL; ARTICLE; DRUG EFFECT; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART VENTRICLE REMODELING; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; RAT; RENOVASCULAR HYPERTENSION; SPRAGUE DAWLEY RAT;

ANIMALS; BERBERINE; COLLAGEN; CYCLIC AMP; CYCLIC GMP; HYPERTENSION, RENOVASCULAR; MALE; MYOCARDIUM; NITRIC OXIDE; ORGAN SIZE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 34247629729     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Tsotetsi QJ, Woodiwiss AJ, Netjhardt M, et al. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats [J]. Hypertension, 2001, 38:846-851.
2. Yamamoto K, Mano T, Yoshida J, et al. ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure [J]. J Hypertens, 2005, 23:393-400.
3. Matsumura K, Fujii K, Oniki H, et al. Role of aldosterone in left ventricular hypertrophy in hypertension [J]. Am J Hypertens, 2006, 19:13-18.
4. Chen H, Zhang L, Zhu D, et al. Effects of diltiazem on myocardial remodeling of left ventricle in renal hypertensive rats [J]. J Fourth Mil Med Univ 2005, 26:594-598.
5. Willette RN, Anderson KM, Nelson AH, et al. Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunction [J]. J Cardiovasc Pharmacol, 2001, 38:606 -617.
6. Sica DA, Gehr TW. Direct vasodilators and their role in hypertension management: minoxidil [J]. J Clin Hypertens (Greenwich), 2001, 3:110-114.
7. Cao X. Berberine's application on treating cardiovascular diseases [J]. Integr Tradit Chin West Med Prac Crit Care Med, 1994, 1:44-46.
8. Yang J, Zhou ZY, Xu JG. Protective effect of berberine on cardiac hypertrophy induced by i-thyroxine in rats [J]. J Sichuan Univ (Med Sci Ed) 2004, 35:223-225.
9. Hong Y, Hui SS, Chan BT, et al. Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy [J]. Life Sci, 2003, 72:2499-2507.
10. Hong Y, Hui SS, Chan TY, et al. Effect of berberine on regression of pressure-overload induced cardiac hypertrophy in rats [J]. Am J Chin Med, 2002, 30: 589-599.
11. Sattar MA, Yusof AP, Can EK, et al. Acute renal failure in 2K2C Goldblatt hypertensive rats during antihypertensive therapy: comparison of an angiotensin ATI receptor antagonist and clonidine analogues [J]. J Auton Pharmacol, 2000, 20:297-304.
12. Brilla CG, Reams GP, Maisch B, et al. Reninangiotensin system and myocardial fibrosis in hypertension ; regulation of the myocardial collagen matrix [J]. Eur Heart], 1993, 14:57-61.
13. Canau A, Devereux RB, Roman M, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension [J]. J Am Coll Cardiol, 1992, 19:1559-1560.
14. Frohlich ED. State of the art lecture. Risk mechanisms in hypertensive heart disease [J]. Hypertension, 1999, 34; 782-789.
15. Chen YG. Renal hypertensive LV hypertrophy and mechanical changes in myocardium after the reverse with drugs [J]. Chin J Cardiac Funct, 1998, 10:221-224.
16. Regitz-Zagrosek V, Nertrampf R, Steffen C, et al. Myocardial cyclic AMP and norepinephrine content in human heart failure [J]. Eur Heart J, 1994, 15:7-13.
17. Ritchie RH, Schiebinger RJ, LaPointe MC, et al. Angiotensin Il-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide [J]. Am J Physiol, 1998, 275:H1370-H1374.
18. Kim NN, Villegas S, Summerour SR, et al. Regulation of cardiac fibroblast extracellular matrix production by bradykinin and nitric oxide [J]. J Mol Cell Cardiol, 1999, 31:457-466.
19. Takizawa T, Gu M, Chobanian AV, et al. Effect of nitric oxide on DNA replication induced by angiotensin II in rat cardiac fibroblasts [J]. Hypertension, 1997, 30:1035 -1040.